David Arkowitz, Director at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 2,500 shares at $12.24 ($31K) on 2017-08-04, disclosed to the SEC on 2017-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.24 | 2,300 | $28K | 92.0% |
| 2 | $12.25 | 200 | $2K | 8.0% |
| Total | $12.24 avg | 2,500 | $31K | 100% |
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |